Lv1
20 积分 2024-04-15 加入
Tumour lysis syndrome: new therapeutic strategies and classification
11天前
已完结
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
18天前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
19天前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
19天前
已完结
Emerging Strategies for the Treatment of Small Cell Lung Cancer
20天前
已完结
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
1个月前
已完结
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
1个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
1个月前
已关闭
PET/CT in Non-Hodgkin Lymphoma: An Update
1个月前
已完结
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
4个月前
已完结
皖公网安备34019202002308
